The new “2022 India Ophthalmic Market Report” features updated forecasts through 2027 measuring the effect of the COVID-19 pandemic on the ophthalmic market and practices, with new analysis of corneal diseases and treatments, blindness, and visual impairment. The report examines newly available technologies, regulatory changes, the role of discount cards and private health insurance, and expansion plans from investor-owned clinics and ASC chains.
The “2022 India Ophthalmic Market Report” analyzes the current landscape of the Indian ophthalmic market, discussing important trends and key factors for future success, and includes forecasts of disease prevalence, numbers of treatments, and technologies used in treatments. The report analyzes the Indian markets for diagnostic equipment, lasers, cataract, refractive, cornea, glaucoma, retina, dry eye, surgical instruments, and single-use surgical devices. Thirty market competitors are profiled, with discussion of their products, strategic market positions, background, and outlook.
Our report is organized into key areas and includes:
2 licensing types are available for this report:
Both licenses include an electronic PDF. Printed copies may be purchased for an additional $250.
SINGLE USER LICENSE
ENTERPRISE LICENSE
Pay by credit card or by invoice.
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.